Katherine E. Harris
Chrono Therapeutics (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Blood Pressure and Hypertension Studies, Glycosylation and Glycoproteins Research, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol(2004)471 cited
- → Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension(2006)269 cited
- → Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol(2003)256 cited
- → nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors(2021)160 cited
- → Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy(2004)131 cited
- → Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol(2004)102 cited
- → Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies(2019)100 cited
- → Abundance, Distribution, and Mutation Rates of Homopolymeric Nucleotide Runs in the Genome of Caenorhabditis elegans(2004)86 cited
- → Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention(2002)85 cited
- → Combination therapy with tirofiban and enoxaparin in acute coronary syndromes(1999)84 cited